Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling. [electronic resource]
- International journal of molecular medicine Apr 2017
- 993-1000 p. digital
Publication Type: Journal Article
1791-244X
10.3892/ijmm.2017.2895 doi
ATP Binding Cassette Transporter, Subfamily B--metabolism Benzylisoquinolines--pharmacology Bone Neoplasms--drug therapy Cell Line, Tumor Drug Resistance, Multiple--drug effects Drug Resistance, Neoplasm--drug effects Humans NF-kappa B--metabolism Neoplasm Proteins--metabolism Osteosarcoma--drug therapy Paclitaxel--pharmacology Signal Transduction--drug effects